• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫苗接种前医护人员中 SARS-CoV-2 感染和血清转化率。

SARS-Cov-2 Infection and Seroconversion Rates in Healthcare Providers Prior to COVID-19 Vaccine Rollout.

机构信息

Sue & Bill Gross School of Nursing, University of California, Irvine, CA, USA.

Department of Microbiology, Immunology and Molecular Genetics, College of Medicine, University of Kentucky, Lexington, KY, USA.

出版信息

Biol Res Nurs. 2023 Oct;25(4):505-515. doi: 10.1177/10998004231161632. Epub 2023 Mar 4.

DOI:10.1177/10998004231161632
PMID:36869766
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9988593/
Abstract

OBJECTIVE

A 6-month longitudinal surveillance study of asymptomatic healthcare providers (HCP) was carried out at a large urban academic medical center in the United States to assess whether their job occupation with higher exposure risks to SARS-CoV-2 would equate with higher risk of contracting COVID-19 at the beginning of the pandemic before COVID-19 vaccines were available.

METHODS

A longitudinal cohort study design was used to collect and analyze immunological and virological monitoring data and self-report survey assessments of personal protective equipment (PPE) availability, adherence to infection control guidelines, and time spent on COVID-19 wards.

RESULTS

Among 289 eligible participants, SARS-CoV-2 exposure risk was high with 48-69% participants working in COVID-19 units and more than 30% of them caring for COVID-19 patients. However, the seroconversion rate was low with only 2.1% of participants developing humoral or cellular immunity against SARS-CoV-2.

CONCLUSION

Our study findings suggest that, for this HCP cohort working at a large urban academic medical center, a low incidence of SARS-CoV-2 infection could be maintained under conditions of strict infection prevention protocols and reliable PPE availability.

摘要

目的

在美国一家大型城市学术医疗中心进行了一项针对无症状医护人员(HCP)的 6 个月纵向监测研究,以评估在 COVID-19 疫苗可用之前大流行初期,他们从事与 SARS-CoV-2 更高暴露风险相关的职业是否会导致更高的 COVID-19 感染风险。

方法

采用纵向队列研究设计,收集和分析免疫和病毒学监测数据以及个人防护设备(PPE)可用性、感染控制指南遵守情况以及在 COVID-19 病房工作时间的自我报告调查评估。

结果

在 289 名符合条件的参与者中,SARS-CoV-2 暴露风险较高,48-69%的参与者在 COVID-19 病房工作,超过 30%的参与者照顾 COVID-19 患者。然而,血清转化率较低,只有 2.1%的参与者对 SARS-CoV-2 产生体液或细胞免疫。

结论

我们的研究结果表明,对于在大型城市学术医疗中心工作的这一 HCP 队列,在严格的感染预防方案和可靠的 PPE 可用性条件下,可以维持 SARS-CoV-2 感染的低发病率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/423a/10500949/bef94b0d3c58/10.1177_10998004231161632-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/423a/10500949/a1873e1816bf/10.1177_10998004231161632-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/423a/10500949/5d06af2b4a14/10.1177_10998004231161632-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/423a/10500949/83fd597ba0ba/10.1177_10998004231161632-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/423a/10500949/82817efd41fc/10.1177_10998004231161632-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/423a/10500949/bef94b0d3c58/10.1177_10998004231161632-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/423a/10500949/a1873e1816bf/10.1177_10998004231161632-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/423a/10500949/5d06af2b4a14/10.1177_10998004231161632-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/423a/10500949/83fd597ba0ba/10.1177_10998004231161632-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/423a/10500949/82817efd41fc/10.1177_10998004231161632-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/423a/10500949/bef94b0d3c58/10.1177_10998004231161632-fig5.jpg

相似文献

1
SARS-Cov-2 Infection and Seroconversion Rates in Healthcare Providers Prior to COVID-19 Vaccine Rollout.新冠疫苗接种前医护人员中 SARS-CoV-2 感染和血清转化率。
Biol Res Nurs. 2023 Oct;25(4):505-515. doi: 10.1177/10998004231161632. Epub 2023 Mar 4.
2
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.一项评估 SARS-CoV-2 疫苗(灭活,Vero 细胞)有效性和安全性的随机、双盲、安慰剂对照 III 期临床试验:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.
3
A prospective cohort study of SARS-CoV-2 infection-induced seroconversion and disease incidence in German healthcare workers before and during the rollout of COVID-19 vaccines.一项在德国卫生保健工作者中开展的前瞻性队列研究,旨在调查 COVID-19 疫苗接种前和接种期间 SARS-CoV-2 感染诱导的血清转换和疾病发病率。
PLoS One. 2024 Jan 30;19(1):e0294025. doi: 10.1371/journal.pone.0294025. eCollection 2024.
4
Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.在医院环境中评估羟氯喹化学预防 SARS-CoV2 感染在医护人员中的疗效和安全性的对照、双盲、随机试验:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):472. doi: 10.1186/s13063-020-04400-4.
5
Estimated COVID-19 vaccine effectiveness against seroconversion from SARS-CoV-2 Infection, March-October, 2021.2021 年 3 月至 10 月估计的 COVID-19 疫苗对 SARS-CoV-2 感染后血清转换的有效性。
Vaccine. 2023 Apr 6;41(15):2596-2604. doi: 10.1016/j.vaccine.2023.03.006. Epub 2023 Mar 9.
6
[Longitudinal Monitoring of Seroconversion Status in SARS-CoV-2 RT-PCR Positive Healthcare Workers].[严重急性呼吸综合征冠状病毒2逆转录聚合酶链反应阳性医护人员血清转化状态的纵向监测]
Mikrobiyol Bul. 2022 Jan;56(1):114-123. doi: 10.5578/mb.20229910.
7
Longitudinal assessment of SARS-CoV-2 IgG seroconversionamong front-line healthcare workers during the first wave of the Covid-19 pandemic at a tertiary-care hospital in Chile.智利一家三级医院在新冠疫情第一波期间对一线医护人员的 SARS-CoV-2 IgG 血清阳转进行的纵向评估。
BMC Infect Dis. 2021 May 26;21(1):478. doi: 10.1186/s12879-021-06208-2.
8
Low SARS-CoV-2 infection rates and high vaccine-induced immunity among German healthcare workers at the end of the third wave of the COVID-19 pandemic.德国医护人员在 COVID-19 大流行第三波末期 SARS-CoV-2 感染率低且疫苗诱导的免疫力高。
Int J Hyg Environ Health. 2021 Sep;238:113851. doi: 10.1016/j.ijheh.2021.113851. Epub 2021 Sep 25.
9
No seroconversion among healthcare workers exposed to SARS-CoV-2 during the early phase of the pandemic.在大流行早期接触 SARS-CoV-2 的医护人员中无血清转换。
Rev Med Chil. 2023 Feb;151(1):23-31. doi: 10.4067/s0034-98872023000100023.
10
COVID-19 infection among emergency department healthcare providers in a large tertiary academic medical center following the peak of the pandemic.大流行高峰期后大型三级学术医疗中心急诊医护人员中的 COVID-19 感染。
Am J Emerg Med. 2021 Feb;40:27-31. doi: 10.1016/j.ajem.2020.11.064. Epub 2020 Dec 2.

本文引用的文献

1
T cell immunity is key to the pandemic endgame: How to measure and monitor it.T细胞免疫是大流行终局的关键:如何测量和监测它。
Curr Res Immunol. 2022;3:215-221. doi: 10.1016/j.crimmu.2022.08.004. Epub 2022 Sep 1.
2
The SARS-CoV-2 omicron wave is indicating the end of the pandemic phase but the COVID-19 will continue.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎毒株引发的疫情浪潮预示着大流行阶段即将结束,但新冠疫情仍将持续。
J Med Virol. 2022 Jun;94(6):2343-2345. doi: 10.1002/jmv.27635. Epub 2022 Feb 4.
3
Evaluation and Comparison of Serological Methods for COVID-19 Diagnosis.
新型冠状病毒肺炎诊断血清学方法的评估与比较
Front Mol Biosci. 2021 Jul 23;8:682405. doi: 10.3389/fmolb.2021.682405. eCollection 2021.
4
SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19.严重急性呼吸综合征冠状病毒2型人类T细胞表位:针对2019冠状病毒病的适应性免疫反应
Cell Host Microbe. 2021 Jul 14;29(7):1076-1092. doi: 10.1016/j.chom.2021.05.010. Epub 2021 May 21.
5
SARS-CoV-2-Specific Antibody and T Cell Response Kinetics According to Symptom Severity.根据症状严重程度评估 SARS-CoV-2 特异性抗体和 T 细胞应答动力学。
Am J Trop Med Hyg. 2021 Jun 17;105(2):395-400. doi: 10.4269/ajtmh.20-1594.
6
A systematic and meta-analysis review on the diagnostic accuracy of antibodies in the serological diagnosis of COVID-19.一项关于新冠病毒病血清学诊断中抗体诊断准确性的系统评价与荟萃分析
Syst Rev. 2021 May 26;10(1):155. doi: 10.1186/s13643-021-01689-3.
7
Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study.血清阳性率和体液免疫对 SARS-CoV-2 抗体在中国武汉的持久性:一项纵向、人群水平、横断面研究。
Lancet. 2021 Mar 20;397(10279):1075-1084. doi: 10.1016/S0140-6736(21)00238-5.
8
Magnitude and Kinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity.抗严重急性呼吸综合征冠状病毒 2 抗体反应的幅度和动力学及其与疾病严重程度的关系。
Clin Infect Dis. 2021 Jan 27;72(2):301-308. doi: 10.1093/cid/ciaa979.
9
Development of a Rapid Focus Reduction Neutralization Test Assay for Measuring SARS-CoV-2 Neutralizing Antibodies.用于检测新型冠状病毒2型中和抗体的快速聚焦减少中和试验分析方法的开发
Curr Protoc Immunol. 2020 Dec;131(1):e116. doi: 10.1002/cpim.116.
10
Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals.新型冠状病毒肺炎住院患者和无症状感染者体内的抗刺突蛋白、抗核衣壳蛋白抗体及中和抗体
Front Microbiol. 2020 Oct 19;11:584251. doi: 10.3389/fmicb.2020.584251. eCollection 2020.